Current situation and perspectives in the treatment of tegumentary

Jaime Soto, .

Keywords: leishmaniasis

Downloads

Download data is not yet available.
  • Jaime Soto Fundación Nacional de Dermatología, FUNDERMA, Santa Cruz, Bolivia

References

Chakravarty J, Sundar S. Current and emerging medications for the treatment of leishmaniasis. Expert Opin Pharmacother. 2019;7:1-15. https://doi.org/10.1080/14656566.2019.1609940
Hefnawy A, Berg M, Dujardin JC, De Muylder G. Exploiting knowledge on leishmania drug resistance to support the quest for new drugs. Trends Parasitol. 2017;33:162-174. https://doi.org/10.1016/j.pt.2016.11.003
Sampaio RNR, Silva JSFE, Paula CDR, Porto C, Motta JOCD, Pereira LIA, et al. A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis. Rev Soc Bras Med Trop. 2019;28;52:e20180292. https://doi.org/10.1590/0037-8682-0292-2018
Machado GU, Prates FV, Machado PRL. Disseminated leishmaniasis: Clinical, pathogenic, and therapeutic aspects. An Bras Dermatol. 2019;94:9-16.
https://doi.org/10.1590/abd1806-4841.20198775
Sosa N, Pascale JM, Jiménez AI, Norwood JA, Kreishman-Detrick M, Weina PJ, et al. Topical paromomycin for New World cutaneous leishmaniasis. PLoS Negl Trop Dis. 2019;2;13(5):e0007253. https://doi.org/ 10.1371/journal.pntd.0007253
Iranpour S, Hosseinzadeh A, Alipour A. Efficacy of miltefosine compared with glucantime for the treatment of cutaneous leishmaniasis: A systematic review and meta-analysis. Epidemiol Health. 2019;31:e2019011. https://doi.org/10.4178/epih.e2019011
How to Cite
1.
Soto J. Current situation and perspectives in the treatment of tegumentary. Biomed. [Internet]. 2019 Jun. 15 [cited 2024 Jul. 27];39(2):237-40. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/5111

Some similar items:

Published
2019-06-15
Section
Editorial

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo
QR Code